Clinical Trial Update: Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy, URO-PRO Trial [Phase 2]

View source ↗

Summary

Phase 2 placebo-controlled trial evaluating Urolithin A supplementation in men with prostate cancer undergoing radical prostatectomy (URO-PRO) is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Adenocarcinoma

Drugs mentioned

• Urolithin A (Urolithin A)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Prostate Adenocarcinoma | Phase 2 | Status: RECRUITING